Product Details
SARS-CoV-2 Nucleic Acid Detection Kit (RT-PCR)
【Intended use】
It is used for qualitative detection of COVID-19 nucleic acid in
throat swab or nasopharyngeal
swab samples. The test results are only used for clinical
reference, and cannot be used as the
basis for diagnosis or exclusion of cases alone.
This kit is based on real-time PCR fluorescence technology to
detect the COVID-19 nucleic acid
of patients with Flu-like symptoms, patients with severe pneumonia
or patients with
asymptomatic infection.
The operators should have professional training of gene
amplification or molecular biological
method detection, have the relevant experimental operation
qualification, and the laboratory shall
have reasonable biological safety prevention facilities and
protection procedures.
【Main Components】
Company Profile
Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan
District, Shenzhen, P.R. China. is a diagnostics company focused on
the development and manufacture of IVD tests at the Point-of-Care
with highly innovative proprietary technology.
We focused on the emerging markets of in vitro pathological
diagnosis and immunodiagnosis. We developed, manufactured and
successfully launched the in vitro immunodiagnosis platform for
cancer and the POCT for infectious, genetic and chronic diseases.
<span style="color: rgb(33, 33, 33); text-transform: none;
text-indent: 0px; letter-spacing: normal;" initial;"="" initial;=""
0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;=""
!important;="" inline="" none;="" 600;="" 14px;="" sans-serif;=""
arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",=""
hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,=""
freesans,="" yahei",="" "microsoft="" helvetica,="" grande",=""
"lucida="" ui",="" segoe="">At Kissh we work every day to shape
the future of in-vitro diagnostic testing. And our people are our
best asset, the reason for our track record and our strength while
we are moving forward. We live by our fundamental values and
incorporate them in everything that we do. Our best asset is ‘Step
Forward Every Second’